Salimetrics Europe launches Salivary CRP (C-Reactive Protein... Cambridge Network, UK - Nov 25, 2008 The Salimerics C-Reactive protein ELISA Kit measures these proteins in saliva, raising research questions about the possibility that minimally invasive ...
Finally, eating something 'bad' is tasty, healthy Glens Falls Post-Star, NY - Nov 29, 2008 ... dark chocolate and its flavonoids is the conclusion that a substance detectable in the body called C-reactive protein (CRP) will decrease significantly. ...
Inflammation Implicated in Another Condition findingDulcinea, New York - Nov 26, 2008 One example it cited was a study that ?found that people with high levels of a marker for inflammation, C-reactive protein, may be twice as likely to ...
Greg?s Happenings by Greg Kristapovich Sierra Mountain Times, CA - People who eat dark chocolate regularly have lower levels of C-reactive protein in their blood, (an indication of inflammation. ...
Recent News and Articles on the Keywords: protein + crp + 106,000 Related to the article below (Last Update: 8/7/2008)
Intravascular Kinetics of C-Reactive Protein and Their ... Journal of Clinical Endocrinology and Metabolism, MD - Objective: The objective of the study was to describe, for the first time, the intravascular kinetics of C-reactive protein (CRP), using stable isotopes, ...
Calorie Restriction Modulates Inactivity-Induced Changes in the ... Journal of Clinical Endocrinology and Metabolism, MD - Bed rest in eucaloric conditions increased plasma C-reactive protein (CRP) (+143 ? 53%) and both the ratios between plasma IL-6 and IL-10 (4?1 times) and ...
Intensive Lipid Intervention in the Post-ENHANCE Era RedOrbit, TX - Aug 5, 2008 Although ezetimibe with simvastatin reduced low-density lipoprotein cholesterol (LDL-C) by 16.5% and C-reactive protein (CRP) by 25.7% beyond the changes ...
Peripheral Arterial Disease: Diagnosis and Management RedOrbit, TX - Aug 5, 2008 Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. ...
4 Medical Tests That Might Save Your Life RedOrbit, TX - Aug 2, 2008 This simple test measures the amount of inflammation in your body by examining levels of highsensitivity C-reactive protein (CRP) in your bloodstream. ...
An open label study to determine the effects of an oral ... 7thSpace Interactive (press release), NY - Jul 24, 2008 It also investigated if any increase would be sufficient to significantly alter nitrogen (N2) balance and C-reactive protein (CRP) levels over control ...
LIVER EXPORT PROTEINS AND TRAUMA - A Fleck, CM Colley, MA Myers - British Medical Bulletin, 1985 - British Council ... 66000 44000 54000 820000 99000 130000 57000 77000 340000 106000... 4 Mechanisms controlling
plasma protein concentration during an acute ...CRP = C-reactiveprotein. ...
Group II Phospholipase A2 in Synovial Fluid and Serum in Acute Arthritis - P Kortekangas, HT Aro, TJ Nevalainen - Scandinavian Journal of Rheumatology, 1994 - informaworld.com ... 67 000 (23 000-106000) 9 ... Concentration of C-reactiveprotein until the analysis of
PLA2 and, if the sample volume was sufficient, CRP contents (25 SF samples). ...
Inventors; and Inventors/Applicants - S LISTING - wipo.int ... In certain embodiments, short antisense compounds are targeted to a nucleic acid
encoding a protein selected from ApoB, SGLT2, PCSK9, SODl, CRP, GCCR, GCGR ...
COMPOUNDS AND METHODS FOR MODULATING EXPRESSION APOB - S Bhanot, RS Geary, R Mckay, BP Monia, PP Seth, AM … - 2007 - freepatentsonline.com ... In certain embodiments, short antisense compounds are targeted to a nucleic acid
encoding a protein selected from ApoB, SGLT2, PCSK9, SODl, CRP, GCCR, GCGR ... -
COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF PTP1B - S Bhanot, RS Geary, R Mckay, BP Monia, PP Seth, AM … - 2007 - freepatentsonline.com ... In certain embodiments, short antisense compounds are targeted to a nucleic acid
encoding a protein selected from ApoB, SGLT2, PCSK9, SODl, CRP, GCCR, GCGR ... -
[CITATION] Deri Bulgular? ile Seyreden Bir Viseral L Olgusu -
While levels of C-reactive protein (CRP) are increasingly used as an inflammation marker for cardiovascular disease, they won`t help predict colorectal cancer risk in women, researchers find.
Reporting in the current issue of the Annals of Internal Medicine, investigators at Brigham and Women`s Hospital, in Boston, say their study of more than 27,000 people found that CRP levels were also of no help in predicting increased risks for developing a certain location or stage of colorectal cancer.
"There was hope based on earlier studies that CRP may be a useful predictor of colorectal cancer risk, in many of the same ways it has been proven to identify individuals at risk for heart disease," study author Dr. Shumin Zhang said in a prepared statement.
"Instead, our findings suggest that low-grade inflammation may not be as important to this disease as we thought, and clinicians will need to keep looking for new ways to predict who is most likely to develop colorectal cancer, a leading cause of cancer deaths in the United States," Zhang said.
Comment by Elizabeth G. Nabel M.D.
